Scorpius Holdings Inc - Company Profile
Powered by 
All the sales intelligence you need on Scorpius Holdings Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Scorpius Holdings Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Scorpius Holdings Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Scorpius Holdings Inc is an integrated contract development and manufacturing organization (CDMO). It focuses on advancing biologic and cell therapy programs to clinical stages. It provides services, including analytical testing, process development, and manufacturing, tailored for pharmaceutical and biotech companies. The company is headquartered in Morrisville, North Carolina, the US.
Headquarters
United States of America
Address
Suite 300, 627 Davis Drive, Morrisville, North Carolina, 27560
Telephone
1 302 6365400
No of Employees
89
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
SCPX (OTC)
Revenue (2023)
$6.2M
-10.7%
(2023 vs 2022)
EPS
XYZ
Net Income (2023)
XYZ
27.4%
(2023 vs 2022)
Market Cap*
$20,000
Net Profit Margin (2023)
XYZ
18.7%
(2023 vs 2022)
* As of and is in US$
Scorpius Holdings Inc premium industry data and analytics
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Divestiture | In December, the company sold the manufacturing and development assets to Tivic Health Systems. |
| 2025 | Contracts/Agreements | In January, the company collaborated with KaloCyte to advance manufacturing for ErythroMer. |
| 2024 | Contracts/Agreements | In January, the company entered into a patent rights sale and assignment agreement with Kopfkino IP, LLC for certain provisional patent applications. |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer